Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINs

Kai Xu1,2, Yiran Wang3, Chen-Hsiang Shen3

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. xu.4692@osu.edu.

Nature Communications
|July 10, 2021
PubMed
Summary

Researchers uncovered how malaria parasites use RIFIN proteins to evade the immune system by binding to the inhibitory receptor LAIR1. This structural insight reveals RIFIN